8 It Should be observed that this variation from published values is due to these batches of toxin being no more accessible for the present Evaluation and using a different batch of Xeomin, in addition to a 5% intervial variability in the manufacturing process (unpublished knowledge 2018, Merz Pharmaceuticals GmbH). https://koreafillerexperts.com/